Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Win a Golden Ticket to Gotland - Sweden´s Summer Island!

Gotland, all-inclusive - for you and three others in July 2024 completely free! Too good to be true? It's true; enjoy Gotland´s legendary hospitality with accommodation, fantastic food, experiences to remember and ferry travel from the mainland for the winner. Gotland has several beautiful beaches for you to enjoy. Credits: Henrik Trygg/imagebank.sweden.se Region Gotland, together with the tourism industry in Gotland, has created this competition to highlight the beautiful island as a place to both visit and live, and to showcase the great range of sustainable experiences

Invitation to presentation of Storskogen’s interim report for the first quarter 2024

On 7 May 2024 at 07:00 (CEST), Storskogen announces its interim report for the first quarter 2024. In connection with the announcement, Christer Hansson, Interim CEO, and Lena Glader, CFO, will hold a presentation followed by a Q&A session. The presentation will be in English and starts at 09:00 (CEST).The presentation and the subsequent Q&A can be followed via webcast or telephone conference. For participation via webcast, please use the following link:https://ir.financialhearings.com/storskogen-group-q1-report-2024   If you wish to participate via telephone conference, please

Notice of annual general meeting in Chosa Oncology AB

The shareholders of Chosa Oncology AB, Reg. No. 559037-2271, are invited to attend the annual general meeting to be held on Friday 31 May 2024 at 1.00 p.m. at Medicon Village, in the main building the Spark, conference room Collaboraction, Scheeletorget 1, Lund, Sweden.Right to participate and notification Shareholders wishing to participate in the annual general meeting must: · partly be listed in the company’s share register kept by Euroclear Sweden AB as of Thursday 23 May 2024; and · partly have notified their participation no later than on Monday 27 May 2024 by post to Chosa

BioStock: Annexin's phase II study fully recruited with positive signals

Annexin Pharmaceuticals has announced that the final patient has been treated in the phase II study with ANXV for the eye disease retinal vein occlusion. A total of 15 patients have been treated, and the results so far show a favorable safety profile and promising efficacy signals. The company is expected to present top-line data during the summer of 2024.Read the article about Annexin Pharmaceuticals here: https://www.biostock.se/en/2024/04/annexins-phase-ii-study-fully-recruited-with-positive-signals/ 

Risk Intelligence enters partnership with Bosch Logistic Operating System for LandRisk Logistics

Risk Intelligence A/S (“Risk Intelligence” or the “Company") announces today that the company has signed a partnership agreement with Bosch Logistics Operating System (“Bosch L.OS”) for integration of Bosch Secure Truck Parking with the LandRisk Logistics as well as referral of Bosch L.OS clients to Risk Intelligence.Through the partnership with Bosch L.OS, users of LandRisk Logistics will be able to seamlessly book and pay for Bosch Secure Truck Parking spaces via the Risk Intelligence System. The integration via Bosch L.OS provides an end-to-end solution for manufacturers and logistics

Publication of Anora’s Interim Report for January–March 2024 on 7 May 2024 and invitation to results presentation

Anora Group Plc   Press release   30 April 2024 at 10:00 a.m. EEST Publication of Anora’s Interim Report for January–March 2024 on 7 May 2024 and invitation to results presentation Anora will publish its Interim Report for January–March 2024 on Tuesday 7 May 2024 at around 8:30 am EEST. CEO Jacek Pastuszka and CFO Sigmund Toth will present the report on the same day at 11:00 am EEST. The presentation will be held as a Microsoft Teams Meeting and we recommend joining the event through the online option: Join meeting here 

AEGIRBIO AB ADVANCES FURTHER WITH “ACCESSIBILITY” MILESTONE COMPLETION IN RADx® TECH PROGRAM

Pioneering Accessibility Project for Multiplex Testing Reaches Key Development MilestoneAegirBio AB is thrilled to announce the successful completion of a pivotal milestone within the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program. Building on the award, AegirBio continues to drive innovation with its digital multiplex self-test platform, specifically designed to improve accessibility for individuals with visual, hearing, and dexterity impairments. The RADx® Tech program, dedicated to expediting diagnostic technology, granted AegirBio an award

New number of shares and votes in Storskogen

The number of shares and votes in Storskogen Group AB (publ) (“Storskogen”), as of today, amounts to 1,686,091,991 (of which 148,001,374 A-shares and 1,538,090,617 B-shares) and 3,018,104,357 votes.As previously announced, the number of shares and votes in Storskogen changed in April due to the conversion of the convertibles which were issued to the sellers of AC Electrical Services Limited on 3 April 2023 totalling GBP 10,361,992 to, in total, 16,561,182 B-shares. The conversion was registered with the Swedish Companies Registration Office on 3 April 2024. The number of shares and votes

The Swiftie Influence: The Top 5 Most Popular Pet Names Inspired By Taylor Swift

Where there are pet owners… there are also Swifties! As a self-proclaimed cat-lover, Taylor Swift has taken the world by storm with her infamous Eras Tour, as well as being recently crowned Spotify’s most listened-to artist of 2023.[1][red iphone 5 c on black textile]     And now, the countdown for her UK tour leg is in motion – with less than six weeks to go until Taylor graces the UK with her presence. As such, it’s of no surprise that many pet owners are consciously (or perhaps even subconsciously) inspired by her when naming their furry friends.   With a notable spike in

CLS partner ClearPoint Neuro receives FDA 510(k) clearance for Prism Bone Anchor Accessory enabling operating room placement of laser applicators

Lund, Sweden, April 30, 2024 – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) today congratulates its partner ClearPoint Neuro on receiving 510(k) clearance for its Prism Bone Anchor Accessory, expanding the use of ClearPoint Prism Neuro Laser Therapy System beyond the MRI into the operating room.The introduction of the Prism Bone Anchor Accessory for use with the ClearPoint Prism Neuro Laser Therapy System and commercially available stereotactic systems allows for placement of laser applicators also in the operating room.   “The 510(k) clearance of the Prism Bone

Archer Limited: Archer secures a 2-year contract extension worth USD 40 million

Hamilton Bermuda, (April 30, 2024) Archer has been awarded a two-year contract extension for platform drilling services in the UK with an estimated contract value of USD 40 million. The extension will commence 1[st] May 2024 in direct continuation of the current contract. Over the next two years Archer will continue to deliver drilling operations, maintenance and rig reactivation services for the customer. Alexander Olsson, EVP Platform Operations in Archer comments: ‘’We are delighted that Archer was elected to continue the work for our client. This contract extension reflects our

MEDIVIR AB – INTERIM REPORT JANUARY – MARCH 2024

”Preparations for the planned phase 2b study continue according to plan after the completed Type C meeting with the FDA, strengthened by the fact that the median time to progression with fostrox + Lenvima increased to 7 months”   January – MarchFinancial summary for the quarter · Net turnover amounted to SEK 0.5 (0.4) million. · The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -26.7 (-18.9) million. Basic and diluted earnings per share amounted to SEK -0.23 (-0.34) and SEK -0.23 (-0.34) respectively. · Cash flow from operating

ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q1 2024

For the second year in a row, we show a positive operating profit for the first quarter. This despite weak construction and consumer markets that resulted in a negative sales development of -12% to MSEK 38.2 (43.5). Thanks to a positive change in product mix and good sales of our own consumer brands, the Group’s gross margin strengthened to 29 (26) %. This, in combination with sound cost control, resulted in a slightly improved operating profit of MSEK 0.2 (0.1).Translation from CEO Mårten Hellbergs comments to the Interim Report. Q1, 1 January - 31 March 2024 The Group compared with

Safello enters into framework agreement with the Swedish Economic Crime Authority

Stockholm, April 30, 2024 | Safello, the leading cryptocurrency exchange in the Nordics, has entered into a framework agreement with the Swedish Economic Crime Authority. The framework agreement between the parties was concluded following a public procurement process conducted by the Swedish Police Authority to meet the needs of the Police Authority, the Swedish Customs Service, and the Economic Crime Authority for cryptocurrency services, which Safello won in August 2023. The procurement was carried out in accordance with the Swedish Public Procurement Act (Lagen om offentlig upphandling, “

Sigrid Therapeutics Surpasses the 50% Enrollment Milestone in its Clinical Trial, SHINE, to Evaluate the SiPore21® Gel for Sustained Diabetes and Obesity Control

· SHINE is the largest ongoing clinical study of its kind, marking a milestone in research on prediabetes and weight control. It involves individuals who are living with excess weight or obesity and have prediabetes or type 2 diabetes. · SiPore21® Silica "Molecular Sieves" is a promising, non-pharmaceutical oral alternative to injectable drugs for sustainable weight control.Stockholm, April 30th, 2024: Sigrid Therapeutics announced today that it has enrolled more than half of the necessary participants for its clinical trial SHINE of SiPore21®. SHINE is a randomized, double-blind,

Resand's solution helps Valmet's foundry industry to increase sand recycling rate

Resand Ltd, press release 30 April 2024 at 9.30 a.m. EESTThe cooperation between Resand Oy, which specializes in foundry sand regeneration and recycling, and Valmet Corporation will expand with the Sand As A Service agreement signed in December 2023. The new agreement includes an environmentally friendly sand recovery and recycling service. The service will significantly increase the recycling rate of the sand used by Valmet's Jyväskylä foundry, while at the same time reducing transport and emissions. The Resand[® ](SAAS) solution offers foundries sustainable savings compared to current

Receives new patent in China

VibroSense Dynamics AB (VibroSense) has got a patent approval in China. The patent describes a principle for measuring skin temperature wirelessly before and during an examination, which ensures measurement quality.Obtaining the patent in China is part of a long-term strategy to protect VibroSense intellectual property rights. The patent protection will be further strengthened by several patent applications currently pending in various countries around the world. The current patent for wireless measurement of skin temperature was approved in Sweden in 2019.VibroSense strategy to protect

The shares in DNB Bank ASA will be quoted ex-dividend today

The shares in DNB Bank ASA will be quoted ex-dividend today (30 April 2024). A dividend of NOK 16 per share will be distributed from 8 May 2024 to shareholders as at 29 April 2024.  For further information, please contact:  Rune Helland, Head of Investor Relations, tel. (+47) 232 68 400 / (+47) 977 13 250 This information is subject to the disclosure requirements according to Section 5-12 of the Norwegian Securities Trading Act.

Dolphin Drilling AS - 2023 Annual Report and ESG report

(Oslo, 30 April 2024) Dolphin Drilling AS (Dolphin Drilling, OSE: DDRIL), has today published the company's Annual Report and ESG report for 2023. The report is attached to this press release and available on www.dolphindrilling.com/Investor Relations. For further information, please contact: Ingolf Gillesdal, Corporate Finance and Investor Relations, tel: +47 920 45 320 Dolphin Drilling | www.dolphindrilling.com

The Swedish Competition Authority prohibits Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB

Oriola Corporation  Stock Exchange Release  30 April 2024 at 9:15 a.m. EEST The Swedish Competition Authority prohibits Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB The Swedish Competition Authority (Konkurrensverket) has announced its decision on prohibiting Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB due to negative effects on the competition in the market. Oriola announced on 13 October 2023 the sale of all shares in Svensk dos AB to Apotekstjänst Sverige AB. Oriola has starting from that announcement communicated that it has not identified a

Pasi Päivärinta appointed as interim CFO of Caverion

Caverion Corporation Stock exchange release 30 April 2024 at 9:00 EETPasi Päivärinta appointed as interim CFO of Caverion Pasi Päivärinta, Head of Group Business Control, has been appointed as interim CFO of Caverion Corporation as of 1 May 2024. He reports to President and CEO of Caverion Corporation Jacob Götzsche and Philip Carlsson, CFO of Assemblin Caverion Group. Päivärinta has worked in the company since 2018. As announced earlier, Caverion Corporation and Assemblin Group AB combined on 1 April 2024 to create a leading northern European technical service and installation

The DOF group awarded multiple contracts with Petrobras

DOF is pleased to announce that Petrobras has awarded new long-term charter and service contracts to Norskan Offshore Ltda. and DOF Subsea Servicos Brasil Ltda, after a competitive tender process.  The vessel Skandi Amazonas (324 t BP) that was on the spot market is chartered for 3 years firm with 2 years mutually agreed option via Petrobras tender issued late in 2023, to operate as a AHTS 270t BP. Vessel is now in process to be adapted to Petrobras contract with expectations to be delivered by mid-May / mid-June 2024. Skandi Rio (206 t BP), currently operating for Petrobras and

There are no items matching the current filter
There are no more items matching the current filter
Back to top